Forge Biologics
June 24, 2026
Theater 1
Type: Company Presentation
Focus Area:
Contract Manufacturing Organization
Forge Biologics, a member of Ajinomoto Bio-Pharma Services, is a gene therapy contract development and manufacturing organization (CDMO) enabling access to life-changing gene therapies by bringing them from concept to reality. Forge’s 200,000 square foot facility, the Hearth, is headquartered in Columbus, Ohio, and houses 20 custom-designed cGMP suites with 20,000L of bioreactor capacity. Forge’s end-to-end, scalable plasmid and AAV manufacturing services include research-grade manufacturing, process and analytical development, cGMP manufacturing, fill and finish, and integrated regulatory support to help accelerate the timelines of transformative medicines for patients with genetic diseases. To learn more, visit www.forgebiologics.com.
Company HQ City:
Grove City
Company HQ State:
Ohio
Company HQ Country:
United States
Year Founded:
2020
Lead Product in Development:
N/A
CEO
John Maslowksi
Development Phase of Lead Product
Other/Not Applicable
Exchange
TSE
Ticker
AJNMY
When you expect your next catalyst update?
N/A
What is your next catalyst (value inflection) update?
N/A
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}